ACADIA PharmaceuticalsACAD

ACADIA Pharmaceuticals

Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders.

CEO
Mr. Stephen R. Davis
4 / 528 reviews
72% recommend to a friend

$4B

Market Cap • 02/06/2023

1993

(30 years ago)
Founded

2004

(19 years ago)
IPO

San Diego

Headquarters • California

513

Employees 2022

Valuation

Valuation Indicators
YearEquityRevenueEBITDAFin. Res.Net Inc.Net Mar.ROECashDebtN.D. / EBITDAOCFCAPEXFCFFreeDiv.
03/23 TTM374520-16210-146LL40361L-5607-560

The values above are represented in USD and the scale is in millions—10.000 is the equivalent of 10 billions. L inside the table means Loss.